GlassScriptPhysician profile
Wing Kee Ng
NPI 1205865995
$955.02
in general payments reported to CMS, 2019-2025
17 companies · $97.43 in 2025
The $97.43 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $639 · 2020: $87.70 · 2022: $45.65 · 2023: $48.67 · 2024: $36.55 · 2025: $97.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $182.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $219.54 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $188.80 | 2019 | |
| Abbvie INC. | $109.35 | 2022-2025 | |
| Tonix Medicines, INC. | $67.35 | 2025 | Tonmya |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $56.05 | 2019-2020 | |
| Amarin Pharma, INC. | $55.29 | 2019-2020 | |
| Allergan, INC. | $43.84 | 2019 | |
| Avanir Pharmaceuticals, INC. | $38.19 | 2019 | |
| Novartis Pharmaceuticals Corporation | $31.68 | 2019-2020 | |
| Lilly USA, LLC | $27.56 | 2019-2020 | |
| Ucb, INC. | $21.09 | 2024 | Briviact |
| Smith+Nephew, INC. | $18.57 | 2019 | |
| Acadia Pharmaceuticals INC | $18.23 | 2019 | |
| Alexion Pharmaceuticals, INC. | $17.69 | 2019 | |
| Boston Scientific Corporation | $15.46 | 2024 | Watchman Flx |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Masimo Corporation | $15.05 | 2023 | Emma and Isa, Set and Rainbow Set |
| Arbor Pharmaceuticals, INC. | $11.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wing Ng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.